| pubmed-article:15165094 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:15165094 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:15165094 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15165094 | pubmed:dateCreated | 2004-5-28 | lld:pubmed |
| pubmed-article:15165094 | pubmed:abstractText | Before now oral vinorelbine has not yet been tested in a cohort of elderly, advanced non-small cell lung cancer patients, even though the intravenous form of this drug provides a reasonable therapeutic option for this group. This trial was conducted to determine the tumor response rate and toxicity profile of oral vinorelbine in advanced non-small cell lung cancer patients > or = 65 years of age. | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15165094 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15165094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15165094 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15165094 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15165094 | pubmed:issn | 0169-5002 | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:JatoiAminahA | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:FitchTom RTR | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:KrookJames... | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:KuglerJohn... | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:NairSureshS | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:RowlandKendri... | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:GeyerSusanS | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:SchulzThomas... | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:KanardAnneA | lld:pubmed |
| pubmed-article:15165094 | pubmed:author | pubmed-author:CastilloReneR | lld:pubmed |
| pubmed-article:15165094 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15165094 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:15165094 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15165094 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15165094 | pubmed:pagination | 345-53 | lld:pubmed |
| pubmed-article:15165094 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:meshHeading | pubmed-meshheading:15165094... | lld:pubmed |
| pubmed-article:15165094 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15165094 | pubmed:articleTitle | Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. | lld:pubmed |
| pubmed-article:15165094 | pubmed:affiliation | Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:15165094 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15165094 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15165094 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15165094 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:15165094 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
